Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?
Open Access
- 11 June 2012
- journal article
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 2
Abstract
Non-HIV Pneumocystis pneumonia (PCP) can occur in immunosuppressed patients having malignancy or on immunosuppressive agents. To classify severity, the A-DROP scale proposed by the Japanese Respiratory Society (JRS), the CURB-65 score of the British Respiratory Society (BTS) and the Pneumonia Severity Index (PSI) of the Infectious Diseases Society of America (IDSA) are widely used in patients with community-acquired pneumonia (CAP) in Japan. To evaluate how correctly these conventional prognostic guidelines for CAP reflect the severity of non-HIV PCP, we retrospectively analyzed 21 patients with non-HIV PCP.Keywords
This publication has 32 references indexed in Scilit:
- Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjectsThorax, 2010
- Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patientsArthritis Care & Research, 2009
- Comparison of severity scoring systems A‐DROP and CURB‐65 for community‐acquired pneumoniaRespirology, 2008
- Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: A retrospective study 2002–2004Scandinavian Journal of Infectious Diseases, 2007
- Detection of Pneumocystis jiroveci in Respiratory Specimens by Four Staining MethodsJournal of Clinical Microbiology, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Pneumocystis carinii Pneumonia in HIV-Infected Patients in the HAART EraAIDS Patient Care and STDs, 2003
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract InfectionsClinical Infectious Diseases, 1992
- General Guidelines for the Clinical Evaluation of Anti-Infective Drug ProductsClinical Infectious Diseases, 1992